Female pattern baldness is a genetic form of hair loss that causes gradual thinning across the top of the scalp while typically leaving the front hairline intact. Known medically as female pattern hair loss, it affects roughly 40% of women by age 50 and is the most common cause of hair loss in women overall. Unlike male pattern baldness, it rarely leads to complete baldness, but it can significantly reduce hair volume over time.
How It Looks and Progresses
The hallmark of female pattern baldness is diffuse thinning over the mid-frontal scalp, most noticeable as a widening center part. The frontal hairline almost always stays in place, which is a key visual difference from male pattern baldness, where the hairline recedes at the temples and a bald spot forms at the crown. Women can develop mild temple recession, but it tends to be subtle and often runs a separate course from the thinning on top.
Severity is commonly graded on a three-level scale developed by Ludwig in 1977. Grade I is perceptible thinning on the crown, starting about one to three centimeters behind the hairline. Grade II is pronounced thinning within that same area. Grade III is full baldness across the crown, but this is rare, affecting less than 1% of women. Most women with female pattern baldness stay in the mild to moderate range.
What Causes It
The condition is driven by a genetically programmed sensitivity in hair follicles to androgens, a group of hormones that includes testosterone and its more potent derivative, DHT. In affected areas of the scalp, follicles carry higher numbers of androgen receptors and produce more DHT. This shortens the growth phase of the hair cycle, causing follicles to gradually shrink. Over successive cycles, the hairs they produce become thinner and shorter until some follicles stop producing visible hair altogether.
Here’s what makes female pattern baldness complicated: most women who have it show completely normal androgen levels in blood tests. They don’t have excess body hair, acne, or irregular periods. This has led researchers to conclude that the problem isn’t necessarily too much androgen circulating in the body, but rather how sensitive the follicles themselves are to normal amounts of it. The ratio of estrogen to androgens may matter more than the absolute level of either hormone.
Why It Often Worsens After Menopause
Estrogen plays a protective role in hair growth. It extends the anagen (growth) phase of the hair cycle and stimulates the production of growth factors that keep follicles active. During menopause, estrogen and progesterone levels drop sharply while androgen levels decline much more gradually. This creates a relative increase in androgen influence, even though androgen levels themselves aren’t rising. The shift helps explain why many women first notice thinning in their late 40s or 50s, and why hair loss that started earlier can accelerate around menopause.
Research from 2018 confirmed that postmenopausal women with pattern hair loss had lower estrogen and higher testosterone and DHT levels compared to postmenopausal women without hair loss. But again, plenty of women develop the condition without any measurable hormonal abnormality, suggesting that follicle-level sensitivity is doing most of the work.
How It Differs From Temporary Hair Shedding
Female pattern baldness is often confused with telogen effluvium, a temporary form of hair shedding triggered by stress, illness, surgery, rapid weight loss, or hormonal shifts like childbirth. The two can even occur simultaneously, which makes distinguishing them tricky. But they behave differently in ways that matter.
Telogen effluvium comes on suddenly. You notice clumps of hair on your pillow or in the shower drain, sometimes seemingly overnight. Studies measuring daily hair shedding found that women with telogen effluvium lose an average of about 250 hairs per day, compared to about 70 per day for women with pattern hair loss alone. Telogen effluvium also causes diffuse thinning all over the scalp, not concentrated along the part line. The good news is that it’s self-limiting. Once the trigger resolves, shedding slows and hair typically regrows within several months.
Female pattern baldness, by contrast, comes on gradually and doesn’t resolve on its own. The shedding rate may not be dramatic, but the hairs that grow back are progressively finer and shorter. If you’re noticing both heavy shedding and a widening part, it’s possible you have both conditions overlapping.
Tests Your Doctor May Run
There’s no single blood test that confirms female pattern baldness. The diagnosis is primarily visual, based on the characteristic thinning pattern. However, doctors typically order bloodwork to rule out other treatable causes of hair loss that can mimic or worsen the condition.
The most commonly checked markers include ferritin (stored iron), thyroid hormones, vitamin B12, vitamin D, and folate. Low levels of any of these can contribute to hair thinning independently. One large study found that lower ferritin, vitamin D, vitamin B12, folate, selenium, and TSH (a thyroid marker) were all significantly associated with hair loss in women, even after adjusting for other factors. If any of these come back low, correcting the deficiency may slow hair loss or improve regrowth, though it won’t reverse pattern baldness itself.
If you have signs of androgen excess like acne, excess facial hair, or irregular periods, your doctor may also check free testosterone and related hormone levels to evaluate for conditions like polycystic ovary syndrome (PCOS).
Topical Treatments
Minoxidil is the most established topical treatment for female pattern baldness and the only one with FDA approval for this use in women. It works by prolonging the growth phase of the hair cycle and increasing blood flow to follicles, though the exact mechanism isn’t fully understood. It doesn’t address the hormonal cause, so hair loss resumes if you stop using it.
A 48-week trial of 381 women compared 5% minoxidil, 2% minoxidil, and placebo applied twice daily. Both concentrations outperformed placebo in objective hair counts and investigator assessments of scalp coverage. The 5% solution was statistically superior to the 2% solution when women rated their own perceived improvement. In practical terms, women using the higher concentration were more likely to feel the treatment was actually working. The 2% formulation is traditionally marketed to women, but many dermatologists now recommend the 5% concentration based on these results.
Expect to use minoxidil for at least four to six months before seeing noticeable improvement. Some women experience a temporary increase in shedding during the first few weeks as resting hairs are pushed out to make room for new growth. This is normal and resolves.
Oral Medications
Spironolactone is the most commonly prescribed oral medication for female pattern baldness. Originally developed as a blood pressure medication, it also blocks DHT from binding to androgen receptors in hair follicles, reducing the miniaturization process. Doses used for hair loss typically range from 100 to 200 mg daily, though some doctors start lower at 25 to 50 mg and increase gradually.
Spironolactone is not appropriate for women who are pregnant or planning to become pregnant, as blocking androgens can affect fetal development. It’s generally used in combination with minoxidil rather than as a standalone treatment, particularly in cases of more advanced thinning or when there’s evidence of elevated androgens.
Platelet-Rich Plasma (PRP) Therapy
PRP involves drawing a small amount of your blood, concentrating the platelets, and injecting them into the scalp. The growth factors in platelets are thought to stimulate dormant follicles. A systematic review covering 776 female participants across multiple trials found that PRP increased both hair density and hair thickness compared to baseline and control groups. Most protocols involve three to four sessions spaced a month apart, with maintenance treatments every few months.
PRP isn’t covered by most insurance plans and typically costs several hundred dollars per session. Results vary widely between individuals, and the treatment is still considered complementary rather than a first-line approach.
Hair Transplants
Hair transplantation is less straightforward for women than for men. The procedure relocates hair follicles from a “donor” area (usually the back of the scalp) to thinning areas. In men with pattern baldness, the donor area tends to be stable and resistant to miniaturization. In women, thinning can be more diffuse, meaning the donor area may also be affected. Research confirms that hair density and diameter at donor sites decline with age, which can further limit candidacy in older women.
Women with a stable, well-defined area of thinning and a healthy donor region can still be good candidates. But the evaluation process is more selective, and a dermatologist specializing in hair loss should assess whether transplanted hairs are likely to survive long-term before proceeding.